An involvement of FABP4 in the pathogenesis of obesity and insulin resistance seems to be mediated via FABP4-dependent peroxisome proliferator-activated receptor γ (PPARγ) inhibition. Here, PPARG is linked to obesity due to melanocortin 4 receptor deficiency.